CD200 and neoplasm: EMT6 tumor growth in CD200-/- hosts did not differ significantly from WT mice, indicating that the lack of CD200 expression in the host did not significantly perturb host resistance, unlike lack of the receptor, CD200R, where CD200R-/- mice were found to show increased resistance [3].